HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA).

16 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

UC San Diego receives $38 million USAID grant to address gender equity and health issues

The U.S. Agency for International Development has funded a $38 million, five-year project led by the Center on Gender Equity and Health at University of California San Diego School of Medicine and Herbert Wertheim School of Public Health and Human Longevity Science.

14 Mar 2022

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

14 Mar 2022

Charts paint a grim picture 2 years into the coronavirus pandemic

The coronavirus pandemic is now stretching into its third year, a grim milestone that calls for another look at the human toll of covid-19, and the unsteady progress in containing it.

7 Mar 2022

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Anthony Cantu, 31, counsels patients at a San Antonio health clinic about a daily pill shown to prevent HIV infection.

3 Mar 2022

Covid expert joins exodus into business, where science parlays into profits

Millions of free covid-19 rapid tests arriving in Americans' mailboxes are long-awaited vindication for Dr. Michael Mina, who, as a Harvard assistant professor, had been advocating for two years that the best way to limit covid is to identify it quickly, cheaply, and widely with rapid antigen tests so infected people know to isolate themselves.

2 Mar 2022

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

Despite overall progress in reducing HIV transmission in the United States, HIV continues to affect some groups more than others due to longstanding and ingrained barriers.

3 Feb 2022

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency.

2 Feb 2022

Researchers call for tailored public health messaging about COVID-19 vaccination for HIV patients

While most people living with HIV have received at least one dose of the COVID-19 vaccine, younger and Black individuals are hesitant to get vaccinated and have lower vaccination rates, according to a new study by Rutgers researchers.

22 Jan 2022

Study reveals how state laws affect access to HIV pre-exposure prophylaxis

State laws in the US that require medical doctors (MDs) to determine which medications a nurse practitioner (NP) or physician assistant (PA) can prescribe, and under what conditions, may limit the number of patients who use HIV pre-exposure prophylaxis (PrEP), reports a study in The Journal of the Association of Nurses in AIDS Care.

22 Jan 2022

Antimicrobial resistance causes more deaths than HIV and malaria

Antibiotic-resistant bacterial infections resulted in more than 1.2 million deaths worldwide in 2019, exceeding the number caused by HIV/AIDS and malaria, says a study spanning 204 countries and territories.

22 Jan 2022

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

The most comprehensive estimate of the global impact of antimicrobial resistance thus far is published in The Lancet today. It reveals that more than 1.2 million people (and potentially millions more) around the world died in 2019 as a direct result of antibiotic-resistant bacterial infections – placing it among the leading causes of death.

19 Jan 2022

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

A new study, posted to the bioRxiv* preprint server, has developed a single-cell atlas that presents the shared and distinct immune responses and metabolism following SARS-CoV-2 and HIV-1 infections.

13 Jan 2022

Common framework evaluates the global health impact of drugs and aids in identifying shortcomings

A common framework that standardizes health impact across diseases and their interventions can aid in identifying current shortcomings on a global scale, according to new research from Binghamton University, State University of New York.

11 Jan 2022

Adding a tomato concentrate to the diet can reduce intestinal inflammation related to HIV

New UCLA-led research in mice suggests that adding a certain type of tomato concentrate to the diet can reduce the intestinal inflammation that is associated with HIV. Left untreated, intestinal inflammation can accelerate arterial disease, which in turn can lead to heart attack and stroke.

11 Jan 2022

HIV/AIDS News and Research

Further Reading

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

UC San Diego receives $38 million USAID grant to address gender equity and health issues

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

Charts paint a grim picture 2 years into the coronavirus pandemic

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Covid expert joins exodus into business, where science parlays into profits

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

Researchers call for tailored public health messaging about COVID-19 vaccination for HIV patients

Study reveals how state laws affect access to HIV pre-exposure prophylaxis

Antimicrobial resistance causes more deaths than HIV and malaria

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

Common framework evaluates the global health impact of drugs and aids in identifying shortcomings

Adding a tomato concentrate to the diet can reduce intestinal inflammation related to HIV

Study finds rise in marijuana use among pregnant and postpartum people living with HIV

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Incarcerated Black individuals experience higher mortality rates, study shows

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News